Exploring the structural activity relationship of the Osimertinib: A covalent inhibitor of double mutant EGFRL858R/T790M tyrosine kinase for the treatment of Non-Small Cell Lung Cancer (NSCLC)
Article in Bioorganic & Medicinal Chemistry (July 2024)
The most recent citing publications are shown below. View all 77 publications that cite this research output on Dimensions.
Article in Bioorganic & Medicinal Chemistry (July 2024)
Article in Cancers (June 2024)
Article in Anti-Cancer Drugs (June 2024)